Literature DB >> 2341721

V region sequences of an idiotypically connected family of pathogenic anti-DNA autoantibodies.

T L O'Keefe1, S Bandyopadhyay, S K Datta, T Imanishi-Kari.   

Abstract

The H and L chain V region sequences of nine anti-DNA mAb that are representative of a pathogenic population of autoantibodies produced by the nephritis prone (SWR x NZB)F1 (SNF1) mice, were determined. These nine anti-DNA autoantibodies were idiotypically connected members of a cross-reactive Id family called the Id564 cluster. Moreover, these autoantibodies were all cationic in charge, IgG2b in isotype, and their H chain C regions had the normal SWR parent's allotype. Although derived from two different SNF1 animals, these pathogenic autoantibodies possessed highly homologous Leader-VH sequences that could account for their idiotypic cross-reactivity. Furthermore, the VH region sequences of these anti-DNA antibodies contained numerous basic residues that could impart their cationic charge. The Leader-VH sequences of these autoantibodies were also highly homologous to that of an anti-NP antibody-related germ-line gene of C57BL/6 mice, called VH-23. Among these nine pathogenic autoantibodies, three sets of clonally related anti-DNA antibodies could be identified. Thus the Id564 cluster of cationic anti-DNA autoantibodies of SNF1 mice are encoded by highly related VH genes, and this idiotypically connected population of pathogenic autoantibodies are selected to undergo an oligoclonal expansion in the lupus-prone SNF1 mice.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2341721

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

Review 1.  T cells of lupus and molecular targets for immunotherapy.

Authors:  S K Datta; A Kaliyaperumal; A Desai-Mehta
Journal:  J Clin Immunol       Date:  1997-01       Impact factor: 8.317

2.  Molecular characteristics of antibodies bearing an anti-DNA-associated idiotype.

Authors:  A Manheimer-Lory; J B Katz; M Pillinger; C Ghossein; A Smith; B Diamond
Journal:  J Exp Med       Date:  1991-12-01       Impact factor: 14.307

3.  Molecular and structural analysis of nuclear localizing anti-DNA lupus antibodies.

Authors:  M H Foster; T Kieber-Emmons; M Ohliger; M P Madaio
Journal:  Immunol Res       Date:  1994       Impact factor: 2.829

4.  Molecular heterogeneity of antigen- or idiotype-induced anti-thyroglobulin monoclonal autoantibodies.

Authors:  C Bedin; A Ropars; K Mignon-Godefroy; J Charreire
Journal:  Clin Exp Immunol       Date:  1995-06       Impact factor: 4.330

Review 5.  Autoreactive T cells in murine lupus: origins and roles in autoantibody production.

Authors:  J Craft; S Peng; T Fujii; M Okada; S Fatenejad
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

Review 6.  B cells and autoantibodies in the pathogenesis of lupus nephritis.

Authors:  M P Madaio
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

7.  Human organ-specific autoimmune disease. Molecular cloning and expression of an autoantibody gene repertoire for a major autoantigen reveals an antigenic immunodominant region and restricted immunoglobulin gene usage in the target organ.

Authors:  G D Chazenbalk; S Portolano; D Russo; J S Hutchison; B Rapoport; S McLachlan
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

Review 8.  Abnormalities in the regulation of variable region genes that encode for antibodies to DNA may be a central factor in the pathogenesis of systemic lupus erythematosus.

Authors:  A K Singh
Journal:  Ann Rheum Dis       Date:  1993-05       Impact factor: 19.103

9.  Independently derived murine glomerular immune deposit-forming anti-DNA antibodies are encoded by near-identical VH gene sequences.

Authors:  M S Katz; M H Foster; M P Madaio
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

Review 10.  Mechanisms of the pathogenic autoimmune response in lupus: prospects for specific immunotherapy.

Authors:  S K Datta; C Mohan; A Desai-Mehta
Journal:  Immunol Res       Date:  1995       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.